Upgrade to SI Premium - Free Trial

StoneX Reiterates Buy Rating on Abbott Labs (ABT)

October 16, 2026 10:05 AM
StoneX analyst Bruce D. Jackson reiterated a Buy rating and $120.00 price target on Abbott Labs (NYSE: ABT).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments